The invention discloses a Chinese medicinal composition for the immunoregulation of
chronic hepatitis B in an
inactive phase or a
carrier state. The Chinese medicinal composition consists of the following medicaments in part by weight: 15 to 30 parts of
astragalus, 10 to 15 parts of largehead atractylodes
rhizome, 10 to 15 parts of
epimedium herb, 10 to 15 parts of glossy
privet fruit, 10 to 15 parts of south dodder seed, 10 to 15 parts of Chinese magnoliavine fruit, 10 to 15 parts of medlar, 15 to 30 parts of red sage root, 15 to 30 parts of
turtle shell, 15 to 60 parts of underleaf pearl, 10 to 15 parts of buffalo horn, and 10 to 30 parts of Chinese honeylocust spine. The Chinese medicinal composition is applicable to the immunoregulation therapy of the CHB in the
inactive phase or a low (non) replicative phase and the
carrier state, is expected to mainly strengthen
body resistance and also clear residual pathogenic factors, has the effects of replenishing qi, tonifying
kidney, dissolving
blood stasis and releasing
toxin, and can well consolidate and maintain the
treatment effect of clinical inactive CHB patients and HBV (
hepatitis B
virus) carriers in an immune tolerant phase and an immune
active phase of CHB .